Pfizer's Covid-19 Vaccine News Is Pushing These 18 Stocks Up - Time To Invest?

Amid some volatility, the S&P 500 has climbed nearly 2.5% in the past week. The triggers? The U.S. elections and, of course, Pfizer'sPFE announcement of successful Covid-19 vaccine phase 3 trials. The latter is more interesting as it brings recovery hopes for some of the most battered industries.